NantHealth, Inc.
NHIQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $94.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.8 |
| Beta | -5.74 |
| Outstanding Shares | 15,008,883 |
Return
| Return on Equity | 28.13% |
|---|---|
| Return on Assets | -48.04% |
| Return on Invested Capital | 99.62% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.47 |
| Enterprise Value to EBIT | -2.13 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.06 |
| Debt to Equity | -0.4 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NantHealth, Inc.
365 employees
CEO: Rao Haris Naseem FACC, NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that cen...